Real-World Clinical and Economic Outcomes Associated with Surgiflo(®) vs Floseal in Cardiovascular Surgeries in the US

BACKGROUND: Topical hemostatic agents are an option for controlling bleeding during cardiovascular surgery. Previous studies comparing topical hemostatic agents in cardiovascular surgery predate the 2012 reformulation of Surgiflo(®), which had been re-engineered to increase paste viscosity and thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Danker, Walter, Aggarwal, Jyoti, Kelkar, Sneha S, Marston, Xiaocong L, Gao, Xin, Johnston, Stephen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922341/
https://www.ncbi.nlm.nih.gov/pubmed/35299991
http://dx.doi.org/10.2147/CEOR.S338672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922341/
https://www.ncbi.nlm.nih.gov/pubmed/35299991
http://dx.doi.org/10.2147/CEOR.S338672

Ejemplares similares